High-level expression of a novel liver-targeting fusion interferon with preferred Escherichia coli codon preference and its anti-hepatitis B virus activity in vivo-Reference-Cited by-同舟云学术

High-level expression of a novel liver-targeting fusion interferon with preferred Escherichia coli codon preference and its anti-hepatitis B virus activity in vivo

Published:2015-06-12 Issue:1 Volume:15 Page:
ISSN:1472-6750
Container-title:BMC Biotechnology
language:en
Short-container-title:BMC Biotechnol

Author:

Lu Xuemei,Wang Jie,Jin Xiaobao,Zhu Jiayong

Publisher

Springer Science and Business Media LLC

Subject

Biotechnology

Link

http://link.springer.com/article/10.1186/s12896-015-0177-1/fulltext.html

Reference28 articles.

1. Kim CK, Choi JH, Lee SB, Lee SM, Oh JW. Expression and purification of recombinant human granulocyte colony-stimulating factor in fed-batch culture of Escherichia coli. Appl Biochem Biotechnol. 2014;172:2425–35.

2. Naz F, Asad M, Malhotra P, Islam A, Ahmad F, Hassan MI. Cloning, expression, purification and refolding of microtubule affinity-regulating kinase 4 expressed in Escherichia coli. Appl Biochem Biotechnol. 2014;172:2838–48.

3. Cao H, Lin R, Ghosh S, Anderson RA, Urban Jr JF. Production and characterization of ZFP36L1 antiserum against recombinant protein from Escherichia coli. Biotechnol Prog. 2008;24:326–33.

4. Qian B, Shen H, Xiong J, Chen L, Zhang L, Jia J, et al. Expression and purification of the synthetic preS1 gene of Hepatitis B Virus with preferred Escherichia coli codon preference. Protein Expr Purif. 2006;48:74–80.

5. Xu Z, Zhong Z, Huang L, Peng L, Wang F, Cen P. High-level production of bioactive human beta-defensin-4 in Escherichia coli by soluble fusion expression. Appl Microbiol Biotechnol. 2006;72:471–9.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon α2–Thymosin α1 Fusion Protein (IFNα2–Tα1): A Genetically Engineered Fusion Protein with Enhanced Anticancer and Antiviral Effect;Materials;2021-06-15

2. Development and biological activity of long-acting recombinant human interferon-α2b;BMC Biotechnology;2020-03-13

3. Production of bioactive liver-targeting interferon Mu-IFN-CSP by soluble prokaryotic expression;AMB Express;2017-10-30

4. Toxicologic evaluations of recombinant liver-targeting interferon IFN-CSP: Genotoxicity and tegenicratoity;Regulatory Toxicology and Pharmacology;2017-10

5. Recent progress in the development of white spot syndrome virus vaccines for protecting shrimp against viral infection;Archives of Virology;2017-06-24